Edward D. Freedman serves as Executive at Pandion Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Edward D. Freedman has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Apr 1, 2021 involved transacting 54,460 shares valued at $3.3M.
Edward D. Freedman currently holds 54,461 shares of Pandion Therapeutics, Inc. (PAND), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Edward D. Freedman has been a net neutral trader of PAND stock. They have purchased $0 and sold $0 worth of shares.
Edward D. Freedman's most recent insider trade was on Apr 1, 2021, when they sold 54,460 shares at $60.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |